For over 14 years, Dr Cengiz was a faculty member with Yale Diabetes Research Group and has conducted diabetes related clinical studies focusing on methods to accelerate insulin action, diabetes technology, and closed-loop systems. She was Director of Yale’s Insulin Pharmacokinetics and Pharmacodynamics (PK-PD) Research Study Center and one of the founding Investigators of the pediatric diabetes registry and type 1 diabetes exchange registry.
Dr. Cengiz’s prospectively designed clinical study (Early Cardiovascular Disease Markers for Children with Type 1 Diabetes (Jerusalem, Israel) (2009-2012), investigates signs of early cardiovascular disease in children with type 1 diabetes in the US and in Israel.